Document is current
Any future updates will be listed below
-
Authors
Khayat, Amal http://orcid.org/0000-0003-0525-4889
Levine, Hagai http://orcid.org/0000-0002-5597-4916
Berg, Carla J. http://orcid.org/0000-0001-8931-1961
Abroms, Lorien C. http://orcid.org/0000-0001-6859-283X
Duan, Zongshuan
Wang, Yan
LoParco, Cassidy R.
Elbaz, Daniel
Cui, Yuxian
Bar-Zeev, Yael http://orcid.org/0000-0002-1916-836X
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA239178-01A1)
- License Information
-
More Information
Article History
Received: 21 February 2024
Accepted: 3 August 2024
First Online: 16 August 2024
Declarations
:
: This study was approved by the Hebrew University, Faculty of Health Ethics Committee (Approval #30112020). All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from participants in the field visits, and recorded oral consent was obtained for those who chose to answer the questions over the phone or via a link.
: Not applicable.
: YBZ has received fees for lectures from Pfizer Ltd, Novartis NCH, and GSK Consumer Health (distributors of smoking cessation pharmacotherapy in Israel) in the past (2012–July 2019). LA receives royalties for the sale of Text2Quit and is a shareholder in Welltok, Inc.
